{"schema_version":"secwatch.filing_event.v1","accession":"0000313616-23-000004","form_type":"8-K","ticker":"DHR","cik":"0000313616","company_name":"DANAHER CORP /DE/","filed_at":"2023-01-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.586130+00:00","generated_at":"2026-06-20T14:17:22.835154+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Danaher splits Life Sciences into Biotechnology and Life Sciences segments, effective Q4 2022","bullets":["New four-segment structure: Biotechnology, Life Sciences, Diagnostics, Environmental & Applied Solutions.","Former Life Sciences segment divided due to growth differences; change reflected retrospectively from Q4 2022.","Unaudited recast historical financial data posted at danaher.com under 'Financial Reports'.","Diagnostics and Environmental & Applied Solutions segments unchanged.","Segments marketed under brands including CYTIVA, PALL, BECKMAN COULTER, SCIEX, and others."],"urls":{"canonical":"https://secwatch.observer/filing/0000313616-23-000004","json":"https://secwatch.observer/filing/0000313616-23-000004.json","markdown":"https://secwatch.observer/filing/0000313616-23-000004.md","text":"https://secwatch.observer/filing/0000313616-23-000004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/313616/000031361623000004/0000313616-23-000004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/313616/000031361623000004/dhr-20230118.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T14:17:22.835154+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}